If my testosterone preparation is 200 mg per milliliter, how many milliliters should I draw to administer a 150 mg dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Testosterone Dose Calculation

To administer 150 mg from a 200 mg/mL testosterone preparation, you need to draw 0.75 mL.

Calculation Method

The calculation is straightforward using the concentration formula:

  • Volume needed = Desired dose ÷ Concentration
  • Volume = 150 mg ÷ 200 mg/mL = 0.75 mL 1

Practical Administration Details

Supplies needed for injection:

  • Use an 18-gauge needle to draw the testosterone from the vial 2
  • Use a 21-23 gauge, 1-1.5 inch needle for the actual intramuscular injection 2
  • A 1-3 mL syringe (3 mL is most common for typical testosterone doses) 2
  • Alcohol prep pads for cleaning the vial top and injection site 2

Injection sites:

  • Self-injection can be performed in the anterolateral thigh 3, 2
  • Gluteal intramuscular injection when administered by another person 3, 2
  • The gluteal muscle can safely accommodate up to 3 mL per injection site 2

Clinical Context for 150 mg Dosing

This 150 mg dose falls within standard testosterone replacement therapy ranges:

  • Testosterone enanthate and cypionate are typically dosed at 100-200 mg every 2 weeks or 50-100 mg weekly 3, 2
  • A 150 mg dose could represent either a weekly injection or part of a biweekly regimen 3
  • Weekly dosing (such as 150 mg weekly) provides more stable testosterone levels compared to biweekly administration 2

Important monitoring considerations:

  • Testosterone levels should be measured 2-3 months after treatment initiation or any dose change, checking midway between injections and targeting mid-normal values of 450-600 ng/dL 2, 4
  • Injectable testosterone carries a higher risk of erythrocytosis (43.8%) compared to transdermal preparations (15.4%), so hematocrit monitoring is mandatory 2
  • The 200 mg biweekly regimen is associated with higher erythrocytosis risk than 100 mg weekly due to greater fluctuation in testosterone levels 5

References

Guideline

Testosterone Replacement Therapy Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

practical use of pharmacotherapy for obesity.

Gastroenterology, 2017

Guideline

Testosterone Enanthate Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.